SCHEMBL19835720

SCHEMBL19835720

O=C(NC(CO)c1nc(-c2cc3ccccc3[nH]2)no1)c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
ALOX15 P16050 1/20 0.40
KDM4E B2RXH2 2/20 0.40
HTT P42858 2/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
PIN1 Q13526 3/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ROCK2 O75116 3/20 0.39
ROCK1 Q13464 2/20 0.38
MAPK13 O15264 1/20 0.38
RPS6KA5 O75582 1/20 0.38
MAP4K4 O95819 1/20 0.38
PAK4 O96013 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18105164 1.00 LMNA (0.44) LMNATSHRALOX15KDM4EHTT
SCHEMBL18105166 0.91 LMNA (0.40) LMNATSHRROCK2ROCK1
SCHEMBL19835929 0.91 LMNA (0.40) LMNATSHRROCK2ROCK1
SCHEMBL18104972 0.83 LMNA (0.40) LMNATSHRNPC1RAB9AROCK2
SCHEMBL19949367 0.83 LMNA (0.40) LMNATSHRNPC1RAB9AROCK2
SCHEMBL19835721 0.82 ALOX15 (0.39) ALOX15CDK2CDK5DYRK1AITK
SCHEMBL19967792 0.82 KDM4E (0.48) LMNATSHRKDM4EHTTALDH1A1
SCHEMBL24386199 0.81 LMNA (0.39) LMNATSHRALDH1A1NPC1RAB9A
SCHEMBL18104994 0.81 LMNA (0.39) LMNATSHRALDH1A1NPC1RAB9A
SCHEMBL19835601 0.80 LMNA (0.42) LMNATSHRKDM4EHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3275440-B1 NOVEL OXADIAZOLE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME NAT CT GERIATRICS & GERONTOLOGY (JP) 2022-05-04 EP disclosed
US-20180072708-A1 NOVEL OXADIAZOLE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) 2018-03-15 US disclosed
EP-3275440-A1 NOVEL OXADIAZOLE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME National Center for Geriatrics and Gerontology (JP) 2018-01-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072708-A1 NOVEL OXADIAZOLE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME APP, BACE1, PSEN1 LMNA 1473/4885TSHR 3747/4885ALOX15 1146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.